Carotid Plaque Length to Predict Cardiovascular Events
1 other identifier
observational
3,000
1 country
5
Brief Summary
This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 3000 patients for suspected CAD who referred to coronary angiography from January 2017 through December 2018.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
June 3, 2022
CompletedFirst Posted
Study publicly available on registry
June 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
ExpectedSeptember 19, 2024
June 1, 2022
5 years
June 3, 2022
September 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
major cardiovascular event
A composite of cardiovascular death, myocardial infarction, and ischemic stroke
3 years
Secondary Outcomes (6)
major vascular event
3 years
all-cause death
3 years
cardiovascular death
3 years
myocardial infarction
3 years
ischemic stroke
3 years
- +1 more secondary outcomes
Study Arms (1)
Carotid plaque length
Patients underwent carotid ultrasonography and first coronary angiography simultaneously
Eligibility Criteria
Patients hospitalized for first coronary angiography and underwent carotid ultrasonography simultaneously
You may qualify if:
- Patientsâ„18 years old, those who underwent carotid ultrasonography and first coronary angiography simultaneously.
You may not qualify if:
- Patients with known coronary artery disease, previous coronary or carotid revascularization, missing carotid ultrasound or coronary angiography results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
No. 904 Hospital of the PLA Joint Logistics Support Force
Wuxi, Jiangsu, 214000, China
Changhai Hospital
Shanghai, Shanghai Municipality, 200000, China
Gongli Hospital
Shanghai, Shanghai Municipality, 200000, China
Putuo Hospital
Shanghai, Shanghai Municipality, 200000, China
Yueyang Hospital
Shanghai, Shanghai Municipality, 200000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pan Li, PhD
Changhai Hospital
- STUDY DIRECTOR
Jian Na, MD
Putuo Hospital
- STUDY DIRECTOR
Liang Chen, MD
904th Hospital of the Joint Logistics Support Force of the PLA
- STUDY DIRECTOR
Wei Zhang, MD
Gongli Hospital
- STUDY DIRECTOR
Yawei Yang, MD
Yueyang Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
June 3, 2022
First Posted
June 8, 2022
Study Start
January 1, 2017
Primary Completion
December 31, 2021
Study Completion (Estimated)
December 31, 2030
Last Updated
September 19, 2024
Record last verified: 2022-06